ProfileGDS4718 / 236853_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 25% 22% 27% 25% 20% 17% 35% 29% 28% 37% 18% 25% 26% 29% 32% 21% 27% 27% 31% 32% 28% 30% 27% 25% 22% 30% 24% 32% 22% 22% 29% 31% 28% 28% 29% 19% 28% 29% 26% 29% 24% 24% 26% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8177236
GSM549102patient 115, normal, homogenized [OPG study]4.3335125
GSM549104patient 119, normal, homogenized [OPG study]4.1997222
GSM549108patient 138, normal, homogenized [OPG study]4.4769827
GSM549119patient 077, normal, homogenized [OPG study]4.3253925
GSM549133patient 032, cancer, homogenized [OPG study]4.1143520
GSM549139patient 042, cancer, homogenized [OPG study]4.0080317
GSM549099patient 107, normal, homogenized [OPG study]4.7815435
GSM549109patient 139, normal, homogenized [OPG study]4.506429
GSM549110patient 046, normal, homogenized [OPG study]4.4623428
GSM549114patient 063, normal, homogenized [OPG study]4.8036637
GSM549122patient 082, normal, homogenized [OPG study]4.0892918
GSM549134patient 033, cancer, homogenized [OPG study]4.3235925
GSM549136patient 036, cancer, homogenized [OPG study]4.3358926
GSM549140patient 044, cancer, homogenized [OPG study]4.4547529
GSM549111patient 047, normal, homogenized [OPG study]4.5952232
GSM549113patient 057, normal, homogenized [OPG study]4.1212921
GSM549132patient 031, cancer, homogenized [OPG study]4.4224527
GSM549137patient 038, cancer, homogenized [OPG study]4.4032127
GSM549142patient 047, cancer, homogenized [OPG study]4.7012831
GSM549100patient 110, normal, homogenized [OPG study]4.6433632
GSM549107patient 135, normal, homogenized [OPG study]4.4260828
GSM549115patient 068, normal, homogenized [OPG study]4.4743230
GSM549116patient 072, normal, homogenized [OPG study]4.4125827
GSM549120patient 078, normal, homogenized [OPG study]4.3415125
GSM549131patient 030, cancer, homogenized [OPG study]4.1791122
GSM549118patient 074, normal, homogenized [OPG study]4.5386230
GSM549129patient 027, cancer, homogenized [OPG study]4.31624
GSM549123patient 088, normal, homogenized [OPG study]4.5930232
GSM549124patient 006, cancer, homogenized [OPG study]4.2678822
GSM549126patient 015, cancer, homogenized [OPG study]4.2158222
GSM549128patient 025, cancer, homogenized [OPG study]4.5000129
GSM549103patient 117, normal, homogenized [OPG study]4.6231231
GSM549117patient 073, normal, homogenized [OPG study]4.424128
GSM549138patient 041, cancer, homogenized [OPG study]4.455928
GSM549141patient 045, cancer, homogenized [OPG study]4.4550229
GSM549130patient 028, cancer, homogenized [OPG study]4.1095319
GSM549101patient 111, normal, homogenized [OPG study]4.4577628
GSM549105patient 128, normal, homogenized [OPG study]4.5118429
GSM549106patient 134, normal, homogenized [OPG study]4.3396726
GSM549112patient 048, normal, homogenized [OPG study]4.4777229
GSM549125patient 011, cancer, homogenized [OPG study]4.3066724
GSM549127patient 024, cancer, homogenized [OPG study]4.2817624
GSM549135patient 035, cancer, homogenized [OPG study]4.3080726